U. Hedin et al., HEPARIN INHIBITS THROMBIN-INDUCED MITOGEN-ACTIVATED PROTEIN-KINASE SIGNALING IN ARTERIAL SMOOTH-MUSCLE CELLS, Journal of vascular surgery, 27(3), 1998, pp. 512-520
Purpose: Smooth muscle cell proliferation is a key event in the develo
pment of intimal hyperplasia after arterial injury. Heparin can suppre
ss smooth muscle cell proliferation in vitro and prevents intimal hype
rplasia after arterial injury, but the mechanisms of action are poorly
understood. Recently, we observed that heparin inhibited serum-induce
d activation of mitogen-activated protein kinase in smooth muscle cell
s, but heparin did not inhibit signaling induced by platelet-derived g
rowth factor BB and basic fibroblast growth factor, both ligands of ty
rosine kinase receptors. Here, we examined the possibility that hepari
n inhibits signaling by thrombin and other activators of heterotrimeri
c G-proteins. Design of Study: Baboon aortic smooth muscle cells were
stimulated with thrombin, angiotensin II, endothelin-l, and lysophosph
atidic acid in the presence or absence of heparin. After stimulation,
mitogen-activated protein kinase activity was measured with an in-gel
phosphorylation assay, mitogen-activated protein kinase kinase-1 was i
mmunoprecipitated from the same samples, and activity was measured wit
h recombinant mitogen-activated protein kinase as a substrate. DNA syn
thesis was measured by H-3-thymidine labeling and scintillation counti
ng. Results: Heparin inhibited sustained activity of mitogen-activated
protein kinase kinase-1 and mitogen-activated protein kinase and prev
ented DNA synthesis induced by thrombin, angiotensin II, endothelin-1,
and lysophosphatidic acid. Conclusions: Heparin inhibits growth of ba
boon smooth muscle cells by preventing prolonged mitogen-activated pro
tein kinase activation elicited by ligands of seven transmembrane doma
in receptors and heterotrimeric G-proteins. The results indicate that
heparin interferes with a specific pathway in smooth muscle cell growt
h, which could be a future target in attempts to inhibit lesion develo
pment after vascular surgery.